Latest news with #GlobalHealthExhibition
Leaders
4 days ago
- Health
- Leaders
KFSHRC Successfully Performs Endoscopic Sleeve Gastroplasty on Kidney Transplant Recipient
In a landmark medical achievement, King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully conducted an Endoscopic Sleeve Gastroplasty (ESG) on a patient with a prior kidney transplant. This complex case involved careful management of immunosuppressive therapy and proactive measures to prevent complications that could compromise the transplanted organ. According to a press release from KFSHRC, this procedure represents a major advancement in delivering safe and effective treatment options for transplant recipients, with the goal of improving graft longevity and enhancing overall quality of life. ESG Unlike traditional surgical sleeve gastrectomy, ESG is a minimally invasive, incision-free procedure. It is performed by inserting an endoscope through the mouth to suture the stomach from the inside, thereby reducing its volume. This method is particularly beneficial for transplant patients, as it minimizes surgical risks while supporting weight loss and improved metabolic health. The primary objective of the procedure was to combat obesity and related metabolic disorders—key factors that can adversely affect kidney transplant outcomes, heighten cardiovascular risk, and reduce long-term patient survival. Moreover, the ESG was carried out by a multidisciplinary team led by Dr. Ehab Abufarhaneh, Consultant in Adult Transplant Gastroenterology and Hepatology. KFSHRC continues to be recognized for its excellence in healthcare. It has been ranked the top academic medical center in the Middle East and North Africa and 15th globally among the world's 250 leading Academic Medical Centers for the third consecutive year. It also holds the title of the most valuable healthcare brand in Saudi Arabia and the Middle East, according to the 2025 Brand Finance rankings. Furthermore, KFSHRC was named among the World's Best Smart Hospitals for 2025 by Newsweek magazine. Related Topics: KFSHRC, Cleveland Clinic Partner to Enhance Autism, Neurosciences Care Riyadh Global Health Exhibition to Bring Together Int'nal Healthcare Experts Intensive Preparations for Smooth, Safe Hajj Season: Mecca Deputy Governor New Chapter Unfolded: Saudi Arabia Launches Electronic Intensive Care Unit Short link : Post Views: 17
CairoScene
29-03-2025
- Health
- CairoScene
Seven New Insulin Products to be Locally Produced in Saudi Arabia
Saudi Arabia signed an agreement to produce at least seven insulin products locally, enhancing its pharmaceutical capabilities and supporting Vision 2030's goals for health security. Oct 24, 2024 On Tuesday, Saudi Arabia signed an agreement to localize at least seven insulin products. The ceremony took place during the Global Health Exhibition in Riyadh and was attended by notable figures, including Minister of Health Fahad Al-Jalajel, Minister of Investment Khalid Al-Falih, and Minister of Industry and Mineral Resources Bandar Alkhorayef. This agreement was forged in collaboration with the National Unified Procurement Company for Medical Supplies (NUPCO), Sudair Pharmaceutical Company, Sanofi, and Novo Nordisk. It underscores Saudi Arabia's commitment to boosting local production capabilities while fostering an attractive investment climate, in alignment with the goals set out in Saudi Vision 2030. The initiative aims to bolster efforts by government agencies, including the Ministries of Health, Investment, and Industry and Mineral Resources, to localize the medical and pharmaceutical sectors. This move aims to achieve drug and health security in the Kingdom while ensuring that domestic pharmaceutical needs and requirements are met effectively.
Zawya
27-01-2025
- Health
- Zawya
Takeda and King Saud University Medical City forge strategic partnership to advance healthcare training in Saudi Arabia
Riyadh, The Kingdom of Saudi Arabia: Takeda, the global biopharmaceutical company, is pleased to announce a new strategic partnership with King Saud University Medical City (KSUMC) to advance healthcare training for medical professionals across Saudi Arabia. With a focus on knowledge exchange, training and awareness initiatives, research and development, and collaboration across digital health and telemedicine solutions, the partnership is designed to support advancements across Saudi Arabia's healthcare system in line with Vision 2030 objectives. The Memorandum of Collaboration (MoC) was signed on the sidelines of the Global Health Exhibition, which recently took place at Riyadh Exhibition and Convention Center, in the presence of Prof. Ahmed bin Salah Hirsi, CEO of King Saud University Medical City and Dr. Khaled Sary, General Manager of Takeda West Gulf Cluster. KSUMC is a multi-facility and multi-disciplinary medical establishment based in Riyadh, renowned for its team of experts and use of advanced medical technologies. The world-class healthcare complex includes more than 1,300 full-time physicians, 853 residents and fellows, and approximately 2,072 allied health personnel. Through this partnership, KSUMC will leverage the competences of the healthcare professionals through Takeda's world-class research and development, and medical innovation in its core therapeutic areas of oncology, rare diseases, neuroscience, gastrointestinal & inflammation, plasma derived therapies, and vaccines. ' As we work toward elevating the quality of healthcare for the citizens of Saudi Arabia in line with Vision 2030, public-private partnerships will continue to play a vital role in achieving core objectives. Our collaboration with Takeda will be critical to advancing knowledge and skills training initiatives while providing access to the latest insights and innovations in the medical field. This will ensure that our healthcare practitioners are empowered to deliver the best patient care possible, ' said Prof. Ahmed bin Salah Hirsi, CEO, King Saud University Medical City. ' With a shared appreciation for the values of patient-centricity and innovation, we believe our recent collaboration with the King Saud University Medical City will fundamentally enhance patient care in terms of diagnosis and treatment. By leveraging our complementary strengths–including KSUMC's local expertise and Takeda's global research and development capabilities–our collaborative efforts will support a more resilient healthcare ecosystem, better adapted to the needs of today's patients. ' said Dr. Khaled Sary, General Manager, Takeda West Gulf Cluster. With a mission to address unmet medical needs and advance sustainable healthcare systems, the partnership with KSUMC exemplifies Takeda's commitment to fostering innovation, empowering healthcare professionals, and enhancing patient outcomes through collaborative efforts across the region. Looking to the near future, Takeda continues to prioritize strategic partnerships across the Middle East region to improve patient care. About Takeda Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries. For more information, visit For more information, please contact. Ronak Thakkar E:
